首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Effect of GuiXiong Xiaoyi Wan in Treatment of Endometriosis on Rats
【2h】

Effect of GuiXiong Xiaoyi Wan in Treatment of Endometriosis on Rats

机译:桂雄小丸丸对子宫内膜异位症大鼠的治疗作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective. To evaluate the effect of GuiXiong Xiaoyi Wan (GXXYW) on the development of endometriosis in a rat model. Methods. Sprague-Dawley rats with surgically induced endometriosis were randomly treated with low-dose GXXYW, high-dose GXXYW, or vehicle (negative control) for 28 days. Immunohistochemistry was used to assess cell proliferation in the lesions. The terminal deoxynucleotidyl transferase- (TdT-) mediated dUTP biotin nick end labelling (TUNEL) method was performed to analyse the apoptosis induced by GuiXiong Xiaoyi Wan. The percentages of CD3+ lymphocytes, CD4+ lymphocytes, and CD8+ lymphocytes in the spleens of the rats were evaluated using flow cytometric analysis. Results. Treatment with GXXYW significantly decreased the lesion size, inhibited cell proliferation, and induced apoptosis in endometriotic tissue. The spleens of GXXYW-treated rats also demonstrated a significant increase in the percentage of CD4+ lymphocytes and a significant decrease in the percentage of CD8+ lymphocytes. Conclusions. These results suggest that, in a rat model, GXXYW may be effective in the suppression of the growth of endometriosis, possibly through the inhibition of cell proliferation, the induction of apoptosis of endometriotic cells, and the regulation of the immune system.
机译:目的。为了评估桂雄消食丸(GXXYW)对大鼠子宫内膜异位症发展的影响。方法。对患有外科子宫内膜异位症的Sprague-Dawley大鼠随机给予小剂量GXXYW,大剂量GXXYW或赋形剂(阴性对照)治疗28天。免疫组织化学用于评估病变中的细胞增殖。进行了末端脱氧核苷酸转移酶(TdT-)介导的dUTP生物素缺口末端标记(TUNEL)方法,分析了归雄小一丸诱导的凋亡。使用流式细胞术分析评估大鼠脾脏中CD3 +淋巴细胞,CD4 +淋巴细胞和CD8 +淋巴细胞的百分比。结果。 GXXYW的治疗显着减少了病变的大小,抑制了细胞的增殖,并诱导了子宫内膜异位组织的凋亡。用GXXYW处理的大鼠的脾脏也显示CD4 +淋巴细胞百分比显着增加,而CD8 +淋巴细胞百分比显着下降。结论。这些结果表明,在大鼠模型中,GXXYW可能通过抑制细胞增殖,诱导子宫内膜异位细胞凋亡以及调节免疫系统来有效抑制子宫内膜异位症的生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号